what does retatrutide target 🚨 HOT OFF THE PRESS: Phase 3 data has arrived — and the obesity medicine world is paying attention. In Lilly's TRIUMPH-1 trial, participants receiving the highest dose achieved an average Retatrutide—A Game Changer in Obesity

Beware Contrary to some beliefs, arctic Indigenous peoples had relatively high rates of cardiovascular disease

Global Inequality in Food and Health Rich countries spend more on costly obesity drugs like GLP-1, even as the world wastes 1.05 billion tonnes of food in 2022 (about 132 kg per person)

A Ready-to-Drink Protein Shake Fairlife Core Power Protein Shakes If youre looking for a ready-to-drink protein shake that you can find at most grocery stores, its hard to beat Fairlife Core Power

and your healthcare provider's input if you manage any metabolic or cardiovascular condition with prescription medication

This analysis helps fill that evidence gap," said John Scott, MD, FACS, FASMBS, clinical professor of surgery at the University of South Carolina School of Medicine Greenville and metabolic and bariatric surgery director for Prisma Health, who was not involved in the study

Latest GLP-1 Study 2025: Key Findings Everyone Is Talking About The latest GLP-1 study 2025 (ATTAIN-1) shows that orforglipron led to meaningful weight loss, better metabolic control, and improvements in heart-related markers